In re Rosuvastatin Calcium Patent Litigation

NOTE: This order is n0nprecede11tial.

United States Court of AppeaIs for the FederaI Circuit

IN RE ROSUVASTATIN CALCIUM PATENT

LITIGATION

ASTRAZENECA UK LIMITED, IPR

PHARMACEUTICALS INC.,

AND SHIONOGI SEIYAKU KABUSHIKI KAISHA, Plain,tiffs-Appellees,

V.

AUROBINDO PHARMA LIMITED,

Defen,dan,t-Appellant, and

MYLAN PHARMACEUTICALS INC.,

Defend0:n,t-Appellant, and

APOTEX CORP.,

Defenclant-Appellant, and

COBALT PHARMACEUTICALS INC. AND COBALT LABORATORIES INC.,

Defendants-Appellants, - and

SUN PHARMACEUTICAL INDUSTRIES, LTD.,

Defendant-Appellan,t,

ASTR.AZENECA V. AUROBINDO 2 and

TEVA PHARMACEUTICALS USA, INC.,

Defendcmt-Appellan.t, and

PAR PHARMACEUTICAL, INC.,

Defendczn,t-Appellant, and

SANDOZ, INC.,

Defend0:n,t.

2010-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473 Appea1s from the United States District Court for the District of De1aware in case nos. 08-MD-1949, 07-CV- 0810, 07-CV-0805, 07-CV-0809, 07-CV-0811, 07-CV-0806, 08-CV-0426, and 07 -CV-0808, Judge J0seph J. Farnan, Jr. ON MOTION

ORDER

Upon consideration of the motion to withdraw Rich- ard A. Kap1an and to substitute Jeffry M. Nich0Is as principal counsel for Teva Pharmaceutica1s USA, Inc., IT ls 0RDERED THAT: _

The motion is granted JefEry M. Nicho1s must promptly enter a new entry of appearance UCT 1 9 2010

Date cc: Char1es E. Lipsey, Esq.

Robert B. Breisblatt, Esq.

Jeffrey S. Ward, Esq.

SteVen A. Maddox, Esq.

Wi1]iam A. Rakoczy, Esq.

Dutch Chung, Esq.

J ames F. Hurst, Esq.

Richard A. Kap1an, Esq.

Jeffry M. Nicho1s, Esq. s21

AsTRAzENEcA v. AURo1-:>.1Nno

FoR THE C0URT /s/ J an Horba1y

J an Horb aly

C1erk

F l..ED

U.S. COURT BF APPEALS FOR

THE FEDERAL C|RCU|T

0CT 1 8 2010 .IANHORBAL‘l

CLERK